As the Trump administration faces backlash over its latest efforts to intensify political control over National Institutes of Health grantmaking, a group of researchers has filed a class-action ...

An FDA advisory committee panel was divided in its consideration of GRAIL’s Galleri multicancer blood test, with members impressed by the test’s ability to detect cancers in patients who are ...

Senate Finance Committee members say documents show CMS plans to expand its controversial, AI-driven Medicare prior authorization model to review time-sensitive medical services like oncology care and ...

CMS’ proposed 20% cuts to key orthopedic services are the most drastic ever and would likely cause practices to close or consolidate as well as threaten patient access to care, according to the ...

Health care advocates are blasting the Trump administration’s cancellation of Affordable Care Act coverage for 750,000 people, and other stakeholders are questioning the timing and impact of the ...

President Trump decried efforts to internationally govern artificial intelligence during a speech at the United Nations General Assembly, where he declared official federal documents would from now on ...

The Trump administration’s pick to head the key behavioral health agency and a Democratic senator butted heads over the efficacy of fentanyl test strips -- and whether they’re required to get funding ...

Uncertainty around funding for the Agency for Healthcare Research and Quality is creating continued concerns about the future of the U.S. Preventative Services Task Force, since AHRQ staff assist in ...

As FDA turns its attention to rare disease treatments, including revisiting controversial decisions from former leaders on gene therapy approvals, newly tapped Center for Drug Evaluation and Research ...

Senate health committee Chair Bill Cassidy (R-LA) said FDA commissioner nominee Heidi Overton will need to acknowledge that President Donald Trump’s recent comments questioning the safety of vaccines ...

ATA Action joined forces with Johns Hopkins Medicine to spearhead a new coalition aimed at narrowly removing specific barriers to telehealth across state lines that is already facilitating ...

Heavily redacted documents detailing the terms Pfizer and Eli Lilly committed to when agreeing to follow the Trump administration’s “most favored nation” pricing framework have generated more ...